Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruiz-Gayo

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|April 22, 1996
A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in miceI Reche, J A Fuentes, M Ruiz-Gayo
British Journal of Pharmacology|May 1, 1996
Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepideF Hernando, J A Fuentes, M Ruiz-Gayo
Neuropharmacology|June 1, 1995
Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphineG Vela, M Ruiz-Gayo, J A Fuentes
Neuropharmacology|July 29, 1998
Inhibition of opioid-degrading enzymes potentiates delta9-tetrahydrocannabinol-induced antinociception in miceI Reche, M Ruiz-Gayo, J A Fuentes
European Journal of Pharmacology|December 17, 1991
In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264C Durieux, M Ruiz-Gayo, B P Roques
European Journal of Pharmacology|December 27, 1996
Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptorsI Reche, J A Fuentes, M Ruiz-Gayo
British Journal of Pharmacology|March 1, 2000
Inhibition of the hypothalamic-pituitary-adrenal axis in food-deprived rats by a CCK-A receptor antagonistM Ruiz-Gayo, M M Garrido, J A Fuentes
British Journal of Pharmacology|July 1, 2008
A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptinV Cano, B Merino, L Ezquerra, et al.
European Journal of Pharmacology|August 22, 1994
The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in miceF Hernando, J A Fuentes, B P Roques, et al.
European Journal of Pharmacology|June 5, 1997
Cyproterone acetate displaces opiate binding in mouse brainM Gutiérrez, L Menéndez, M Ruiz-Gayo, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|April 22, 1996
A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in miceI Reche, J A Fuentes, M Ruiz-Gayo
British Journal of Pharmacology|May 1, 1996
Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepideF Hernando, J A Fuentes, M Ruiz-Gayo
Neuropharmacology|June 1, 1995
Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphineG Vela, M Ruiz-Gayo, J A Fuentes
Neuropharmacology|July 29, 1998
Inhibition of opioid-degrading enzymes potentiates delta9-tetrahydrocannabinol-induced antinociception in miceI Reche, M Ruiz-Gayo, J A Fuentes
European Journal of Pharmacology|December 17, 1991
In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264C Durieux, M Ruiz-Gayo, B P Roques
European Journal of Pharmacology|December 27, 1996
Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptorsI Reche, J A Fuentes, M Ruiz-Gayo
British Journal of Pharmacology|March 1, 2000
Inhibition of the hypothalamic-pituitary-adrenal axis in food-deprived rats by a CCK-A receptor antagonistM Ruiz-Gayo, M M Garrido, J A Fuentes
British Journal of Pharmacology|July 1, 2008
A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptinV Cano, B Merino, L Ezquerra, et al.
European Journal of Pharmacology|August 22, 1994
The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in miceF Hernando, J A Fuentes, B P Roques, et al.
European Journal of Pharmacology|June 5, 1997
Cyproterone acetate displaces opiate binding in mouse brainM Gutiérrez, L Menéndez, M Ruiz-Gayo, et al.
Pageof 4